Diabetes mellitus, coronary artery disease and heart disease (Update 2023)

被引：2

作者：

Clodi, Martin ^{[1
,2
]}

Saely, Christoph H. H. ^{[3
,4
,5
]}

Hoppichler, Friedrich ^{[6
]}

Resl, Michael ^{[1
,2
]}

Steinwender, Clemens ^{[7
]}

Stingl, Harald ^{[8
,9
]}

Wascher, Thomas C. C. ^{[10
]}

Winhofer, Yvonne

Sourij, Harald

机构：

[1] Konventhosp Barmherzigen Bruder Linz, Abt Innere Med, Linz, Austria

[2] Johannes Kepler Univ Linz, Klin Forschungsinst Kardiometab Forsch, Altenberger Str 69, A-4040 Linz, Austria

[3] VIVIT Inst Feldkirch, Feldkirch, Austria

[4] Private Univ Furstentum Liechtenstein, Triesen, Liechtenstein

[5] Akad Lehrkrankenhaus Feldkirch, Abt Innere Med I, Feldkirch, Austria

[6] Krankenhaus Barmherzigen Bruder Salzburg, Abt Innere Med, Salzburg, Austria

[7] Kepler Univ Klinikum Linz, Klin Kardiol & internist Intens Med, Linz, Austria

[8] Karl Landsteiner Univ Gesundheitswissensch, Krems An Der Donau, Krems, Austria

[9] Landesklinikum Baden, Abt Innere Med, Baden, Austria

[10] Mein Hanusch Krankenhaus, Med Abt 1, Vienna, Austria

来源：

WIENER KLINISCHE WOCHENSCHRIFT | 2023年 / 135卷 / SUPPL 1期

关键词：

Diabetes mellitus; Heart failure in diabetes; Coronary artery disease; Heart failure; Screening; CARDIOVASCULAR RISK-ASSESSMENT; GLYCEMIC CONTROL; TYPE-2; OUTCOMES; EVENTS; FAILURE; METFORMIN; MORTALITY; ATHEROSCLEROSIS; PIOGLITAZONE;

D O I：

10.1007/s00508-023-02183-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with preexisting diabetes mellitus. In patients with previously diagnosed arterosclerotic cardiovascular disease an agent proven to reduce major adverse cardiovascular events or cardiovascular mortality is recommended.

引用

页码：201 / 206

页数：6

共 37 条

[1] Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics [J].

Abudureyimu, Miyesaier ;

Luo, Xuanming ;

Wang, Xiang ;

Sowers, James R. ;

Wang, Wenshuo ;

Ge, Junbo ;

Ren, Jun ;

Zhang, Yingmei .

JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, 14 (05)

[2] Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study [J].

Andersson, C. ;

Olesen, J. B. ;

Hansen, P. R. ;

Weeke, P. ;

Norgaard, M. L. ;

Jorgensen, C. H. ;

Lange, T. ;

Abildstrom, S. Z. ;

Schramm, T. K. ;

Vaag, A. ;

Kober, L. ;

Torp-Pedersen, C. ;

Gislason, G. H. .

DIABETOLOGIA, 2010, 53 (12) :2546-2553

[3]

McDonagh Theresa A, 2021, Eur Heart J, V42, P3599, DOI [10.1002/ejhf.2333, 10.1016/j.rec.2022.05.005, 10.1093/eurheartj/ehab368]

[4] A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease [J].

Frye R.L. ;

August P. ;

Brooks M.M. ;

Hardison R.M. ;

Kelsey S.F. ;

MacGregor J.M. ;

Orchard T.J. ;

Chaitman B.R. ;

Genuth S.M. ;

Goldberg S.H. ;

Hlatky M.A. ;

Jones T.L.Z. ;

Molitch M.E. ;

Nesto R.W. ;

Sako E.Y. ;

Sobel B.E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (24) :2503-2515

[5] Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient The Imaging Council of the American College of Cardiology [J].

Budoff, Matthew J. ;

Raggi, Paolo ;

Beller, George A. ;

Berman, Daniel S. ;

Druz, Regina S. ;

Malik, Shaista ;

Rigolin, Vera H. ;

Weigold, Wm Guy ;

Soman, Prem .

JACC-CARDIOVASCULAR IMAGING, 2016, 9 (02) :176-192

[6] Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum [J].

Cefalu, William T. ;

Kaul, Sanjay ;

Gerstein, Hertzel C. ;

Holman, Rury R. ;

Zinman, Bernard ;

Skyler, Jay S. ;

Green, Jennifer B. ;

Buse, John B. ;

Inzucchi, Silvio E. ;

Leiter, Lawrence A. ;

Raz, Itamar ;

Rosenstock, Julio ;

Riddle, Matthew C. .

DIABETES CARE, 2018, 41 (01) :14-31

[7] Prognostic Significance of Silent Myocardial Infarction in Newly Diagnosed Type 2 Diabetes Mellitus United Kingdom Prospective Diabetes Study (UKPDS) 79 [J].

Davis, Timothy M. E. ;

Coleman, Ruth L. ;

Holman, Rury R. .

CIRCULATION, 2013, 127 (09) :980-+

[8] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[9] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes [J].

Duckworth, William ;

Abraira, Carlos ;

Moritz, Thomas ;

Reda, Domenic ;

Emanuele, Nicholas ;

Reaven, Peter D. ;

Zieve, Franklin J. ;

Marks, Jennifer ;

Davis, Stephen N. ;

Hayward, Rodney ;

Warren, Stuart R. ;

Goldman, Steven ;

McCarren, Madeline ;

Vitek, Mary Ellen ;

Henderson, William G. ;

Huang, Grant D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) :129-U62

[10] Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus [J].

Evans, Josie M. M. ;

Doney, Alex S. F. ;

AlZadjali, Matlooba A. ;

Ogston, Simon A. ;

Petrie, John R. ;

Morris, Andrew D. ;

Struthers, Allan D. ;

Wong, Aaron K. F. ;

Lang, Chim C. .

AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07) :1006-1010

← 1 2 3 4 →